Epidemiology and clinical presentation of hepatocellular carcinoma

被引:1
|
作者
Kubicka, S [1 ]
Manns, MP [1 ]
机构
[1] Med Hochschule Hannover, Abt Gastroenterol Endokrinol & Hepatol, Zentrum Innere Med, D-30625 Hannover, Germany
来源
CHIRURGISCHE GASTROENTEROLOGIE | 2003年 / 19卷 / 03期
关键词
hepatocellular carcinoma; epidemiology; prognosis;
D O I
10.1159/000074005
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Hepatocellular carcinomas are one of the main complications of liver cirrhosis and a serious health problem worldwide. The incidence of hepatocellular carcinoma varies between different countries, depending on the prevalence of several risk factors such as chronic viral hepatitis B or C, contamination of food with aflatoxin, and alcohol abuse. The incidence of hepatocellular carcinoma is low in developed Western countries, but in some areas of Africa or China, hepatocellular carcinoma is the major cause of tumor-related death. The incidence of hepatocellular carcinoma is rising in all developed Western countries, which can be explained, at least in part, by the increasing prevalence of hepatitis C virus infection. The development of hepatocellular carcinoma in patients with chronic hepatitis C infection needs approximately 20-30 years. Consequently, it has been predicted that the burden of hepatocellular carcinoma in developed Western countries will increase in the next 2-3 decades, possibly to equal rates as currently experienced in Japan. Although liver cirrhosis per se appears to be the primary risk factor for hepatocellular carcinoma, hepatocarcinogenesis strongly depends also on the causes of liver cirrhosis. Depending on the underlying disease, patients with high risk (chronic viral hepatitis B or C, hemochromatosis, tyrosinemia) and those with low risk (morbus Wilson, primary biliary cirrhosis, primary sclerosing cholangitis) for the development of hepatocellular carcinoma can be identified. The prognosis of patients with hepatocellular carcinoma is independent of the underlying disease, but depends on the liver function and the tumor stage.
引用
收藏
页码:214 / 217
页数:4
相关论文
共 50 条
  • [1] Epidemiology and clinical presentation of hepatocellular carcinoma
    Di Bisceglie, AM
    [J]. JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY, 2002, 13 (09) : S169 - S171
  • [2] Hepatocellular carcinoma: Epidemiology and clinical aspects
    Mazzanti, Roberto
    Gramantieri, Laura
    Bolondi, Luigi
    [J]. MOLECULAR ASPECTS OF MEDICINE, 2008, 29 (1-2) : 130 - 143
  • [3] Clinical presentation and natural course of hepatocellular carcinoma
    Bialecki, ES
    Di Biscleglie, AM
    [J]. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2005, 17 (05) : 485 - 489
  • [4] AN UNUSUAL CLINICAL PRESENTATION OF HEPATOCELLULAR-CARCINOMA
    LONG, R
    BETSILL, WL
    [J]. ACTA CYTOLOGICA, 1988, 32 (05) : 767 - 767
  • [5] Hepatocellular carcinoma in an Australian tertiary referral hospital 1975-2002: Change in epidemiology and clinical presentation
    Roberts, Stuart K.
    Kemp, William
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2007, 22 (02) : 191 - 196
  • [6] Epidemiology, Clinical Staging, and Presentation of Renal Cell Carcinoma
    DeCastro, G. Joel
    McKiernan, James M.
    [J]. UROLOGIC CLINICS OF NORTH AMERICA, 2008, 35 (04) : 581 - 592
  • [7] Hepatocellular carcinoma in Austria:: aetiological and clinical characteristics at presentation
    Schöniger-Hekele, M
    Müller, C
    Kutilek, M
    Oesterreicher, C
    Ferenci, P
    Gangl, A
    [J]. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2000, 12 (08) : 941 - 948
  • [8] Hepatocellular carcinoma and the Fontan circulation: Clinical presentation and outcomes
    Possner, Mathias
    Gordon-Walker, Timothy
    Egbe, Alexander C.
    Poterucha, Joseph T.
    Warnes, Carole A.
    Connolly, Heidi M.
    Ginde, Salil
    Clift, Paul
    Kogon, Brian
    Book, Wendy M.
    Walker, Niki
    Wagenaar, Lodewijk J.
    Moe, Tabitha
    Oechslin, Erwin
    Kay, W. Aaron
    Norris, Mark
    Dillman, Jonathan R.
    Trout, Andrew T.
    Anwar, Nadeem
    Hoskoppal, Arvind
    Broering, Dieter C.
    Bzeizi, Khalid
    Veldtman, Gruschen
    [J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 2021, 322 : 142 - 148
  • [9] Epidemiology of hepatocellular carcinoma
    Kew, MC
    [J]. TOXICOLOGY, 2001, 164 (1-3) : 4 - 4
  • [10] Epidemiology of hepatocellular carcinoma
    Yu, MC
    Yuan, JM
    Govindarajan, S
    Ross, RK
    [J]. CANADIAN JOURNAL OF GASTROENTEROLOGY, 2000, 14 (08): : 703 - 709